Kura Oncology (KURA) Tops Q4 EPS by 35c

Kura Oncology (NASDAQ: KURA) reported Q4 EPS of ($0.22), $0.35 better than the analyst estimate of ($0.57).

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• Kalshi in early talks for IPO - The Information
• SanDisk and Micron surge as Apple confirms memory price pass-through
• Happy Belly Food Group raises $8.35M through warrant exercises